Product/Composition:- | Teniposide |
---|---|
Strength:- | 50 mg/5 mL (10 mg/mL vial) |
Form:- | Injection (IV) |
Reference Brands:- | Vumon® (EU & US) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Teniposide is a topoisomerase II inhibitor used in oncology, primarily for treating acute lymphoblastic leukemia (ALL) in pediatric patients. Marketed under the brand name Vumon®, it is available in 50 mg/5 mL (10 mg/mL) IV vials in both the US and EU. Teniposide is a critical component in combination chemotherapy protocols and is supplied under GMP-compliant manufacturing. Ideal for pharma B2B partners, Teniposide supports trusted oncology supply chains across regulated markets.
Teniposide Injection is a potent chemotherapeutic agent used in the treatment of acute lymphoblastic leukemia (ALL), especially in pediatric patients with relapsed or refractory disease. Classified as a topoisomerase II inhibitor, Teniposide disrupts DNA replication and cell division, making it effective in oncology protocols. It is commercially available in the US and EU under the brand name Vumon®, typically in 50 mg/5 mL (10 mg/mL) injectable vials. Teniposide is manufactured under strict GMP standards, making it ideal for B2B pharmaceutical distributors, hospital tenders, and global supply chains seeking reliable oncology solutions in regulated markets.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications